We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biologics Firm Draws FDA Warning Letter for Unapproved Cellular Products
Biologics Firm Draws FDA Warning Letter for Unapproved Cellular Products
The FDA has issued a warning letter to a Lake Forest, Calif.-based biologics company, Invitrx Therapeutics, for selling unapproved allogenic cellular-derived drugs, including a human umbilical cord-derived product.